Cardiovascular ESC 2005

Fondaparinux: Better than Enoxaparin for Patients with Acute Coronary Syndromes?

September 12, 2005

AudioMedica News

00:00 /

Freek Verheugt

Shamir Mehta of McMaster University told Audio Medica in Stockholm about the OASIS-5/MICHELANGELO results comparing the new anti-thrombotic therapy, fondaparinux, with enoxaparin among patients with acute coronary syndromes. For a comment on Shamir Mehta’s presentation at the ESC meeting, Audio Medica questioned Freek Verheugt of Nijmegen.
Shamir Mehta: [audio:https://www.audiomedica.com/podcasting/08.Shamir_Mehta.mp3]
Freek Verheugt: [audio:https://www.audiomedica.com/podcasting/09.Freek_Verheugt.mp3]

Click here for all the interviews from ESC 2005

Tagged as:oasis patient therapy

COVID-19 Co-Morbidity Risks Quantified from Three Continents Survey

May 28, 2020

Mandeep Mehra talks about his report in the New England Journal of Medicine on the inflammatory effects of COVID-19 infection and the implications...

Audio Cardiovascular

Competitive and Leisure Sports: Recommendations to Minimise Cardiovascular Risk

August 28, 2016

Atrial fibrillation is prevented by exercise and life-long endurance athletes do not face the same elevated risks of stroke and heart disease from...

Audio Cardiovascular

AudioMedica.com with MDFM: Novel oral anticoagulants: latest opinion from the ESC congress

October 3, 2013

AMSTERDAM—Whether triple anti-thrombotic therapy should be accepted as generally the optimal approach for treating patients at high risk of having a...

Cardiovascular

SAVOR-TIMI 53 study: saxagliptin had better glucose control than placebo but no cardiovascular benefit

September 22, 2013

AMSTERDAM — The SAVOR-TIMI 53 study in 16 000 patients has confirmed the efficacy of the DPP-4 inhibitor, saxagliptin, for controlling glycaemia in...

Cardiovascular

Novel oral anticoagulants: latest opinion from the ESC congress

September 22, 2013

AMSTERDAM—Whether triple anti-thrombotic therapy should be accepted as generally the optimal approach for treating patients at high risk of having a...

Cardiovascular

Young adults less likely to be diagnosed with hypertension than over 60s

December 31, 2012

AudioMedica News Young adults less likely to be diagnosed with hypertension than over 60s Play Episode Pause Episode Mute/Unmute Episode Rewind 10...

Fondaparinux: Better than Enoxaparin for Patients with Acute Coronary Syndromes?

Further reading

COVID-19 Co-Morbidity Risks Quantified from Three Continents Survey

Competitive and Leisure Sports: Recommendations to Minimise Cardiovascular Risk

AudioMedica.com with MDFM: Novel oral anticoagulants: latest opinion from the ESC congress

SAVOR-TIMI 53 study: saxagliptin had better glucose control than placebo but no cardiovascular benefit

Novel oral anticoagulants: latest opinion from the ESC congress

Young adults less likely to be diagnosed with hypertension than over 60s

Menu